American Mosquito Control Association (AMCA):
The American Mosquito Control Association (AMCA) Research Fund invites new pre-proposals for research on mosquito control and related topics for 2020.
AMCA is a nonprofit organization that is dedicated to providing leadership, information, and education leading to the enhancement of public health and quality of life through the suppression of mosquitoes. The AMCA Research Fund is devoted to funding research that will lead to new tools and strategies for mosquito surveillance and control and ultimately protecting the public from mosquito-borne disease and discomfort from mosquito bites.
PRIORITY AREAS: In general, AMCARF seeks to support research that:
- Enhances public mosquito and vector control agency mosquito control programs
- Originates from young researchers building their careers
- Originates from and/or includes researchers from Mosquito Control Districts
AMCARF (funding cycle of 2020), is requesting proposals for projects investigating:
- Chronic and/or acute impact of pesticides applied for mosquito control on non-target organisms
- Adulticides and/or larvicides: new products research
The 2020 AMCARF is targeted to these two research areas; however, pre-proposals submitted with a research focus area other than those listed above will be considered by the pre-proposal review committee. Applicants with the top pre-proposals will be invited to submit full proposals. Pre-proposals will be reviewed and the top project PIs notified by mid-August. Please refer to the RFP for full requirements.
- Awards: Up to $55,000 for one year.
- Deadline: Pre-proposals due June 21, 2019
National Institutes of Health (NIH):
Notice of Intent to Publish a Funding Opportunity Announcement for Specialized Centers of Excellence on Environmental Health Disparities Research (P50)
The National Institute on Minority Health and Health Disparities (NIMHD), in partnership with the National Institute of Environmental Health Sciences (NIEHS), intends to publish a Funding Opportunity Announcement (FOA) to solicit applications from eligible institutions of higher education for specialized research center grants to conduct multidisciplinary research, research capacity building, and community-engaged research activities focused on understanding and reducing or eliminating environmentally-driven health disparities.
Projects must include a focus on one or more NIH-designated health disparities populations in the United States: Blacks or African Americans, American Indians or Alaska Natives, Asians, Hispanics or Latinos, Native Hawaiians and other Pacific Islanders, socioeconomically disadvantaged populations, underserved rural populations, and sexual and gender minorities. Comparison groups/populations may also be included as appropriate for the research questions posed.
This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. This FOA will utilize the P50 activity code. Details of the planned FOA are provided in the link.
- Estimated Publication Date of Funding Opportunity Announcement: August 01, 2019
- First Estimated Application Due Date: November 15, 2019
Early-Stage Preclinical Validation of Therapeutic Leads for Diseases of Interest to the NIDDK (R01 Clinical Trial Not Allowed)
The goal of this Funding Opportunity Announcement (FOA) is to support translational research that provides strong justification for later-phase therapeutics discovery and development efforts in health-related outcomes relevant to the National Institute of Diabetes and Digestive and Kidney Diseases. This includes outcomes relevant to obesity, diabetes and related aspects of endocrinology and metabolism, digestive diseases, liver diseases, nutrition, kidney and urological diseases, and hematology. Additional information concerning programmatic areas at NIDDK is available at www.niddk.nih.gov/research-funding/research-programs/Pages/default.aspx and applicants are strongly encouraged to discuss research priorities with the Scientific Contact.
The objective of this FOA is to stimulate early-stage preclinical validation of therapeutic leads (that need not be finalized therapeutics, henceforth called “therapeutic leads”) such as small molecules or non-viral biologics that are not currently a focus within the biotechnology and pharmaceutical industries. It is expected that there is significant novelty in the target, small molecule, or non-viral biologic and in how the resulting therapeutic would differentiate from existing therapies. This must be articulated clearly in the application. It is not intended to support research focused on understanding normal biology, disease processes, generating lists of putative new targets, or identifying new therapeutic uses for existing compounds.
At the end of the project period, a successful project will have provided a significant contribution to the data supporting the validity around a therapeutic such that it can advance further through other funding mechanisms, such as the small business program (https://sbir.nih.gov/niddk/index).
- Awards: Application budgets are not limited but need to reflect the actual needs of the proposed project. Maximum project period is five years.
- Deadlines: Applications due Nov 12, 2019, July 14, 2020, Nov 12, 2020, July 14, 2021, and Nov 12, 2021.
NIAID New Innovators Awards (DP2 Clinical Trial Not Allowed)
The NIAID New Innovator Awards supports post-doctoral investigators of exceptional creativity who propose highly innovative bold new research with the potential to produce a major impact on broad, important problems in biomedical research of priority to NIAID. Applications from individuals with diverse backgrounds and in any topic relevant to the mission of NIAID are welcome.
- Awards: $300,000 in direct cost per year for up to 5 years.
- Deadlines: Applications due October 10, 2019, October 14, 2020, October 13, 2021.
Limited Submission Opportunities (https://vpr.tamu.edu/initiate-research/lsp):
NIFA will hold a grantsmanship webinar June 11 from 1:30 to 3 p.m. EDT to provide information on the AFRI Foundational Applied Science Food Safety, Nutrition and Health Program Area. Use the AFRI-FSNH webinar link to join. Consider viewing in groups as attendee slots are limited. The webinar will be recorded and posted to the NIFA website.
This webinar will provide an overview of:
- Food Safety and Defense
- Novel Foods and Innovative Manufacturing Technologies
- Diet, Nutrition and the Prevention of Chronic Diseases
- Food and Human Health
- Mitigating Antimicrobial Resistance across the Food Chain
NIFA is soliciting topics commodity board entities (federal and state-level commodity boards, as defined below) are willing to co-fund equally with NIFA. To be considered for inclusion in future Agriculture and Food Research Initiative (AFRI) competitive grants program Requests for Applications (RFAs), topics must relate to the established priority areas of AFRI. Commodity boards may submit topics at any time; however, all topics received by 5 p.m. EDT on Aug. 5, will be considered for fiscal year 2020 AFRI RFAs.